Top Buy
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corp. | 25 | 1 | 3 | 0 | €79.20 | €87.48 | 10.448% |
| CONMED Corp. | 11 | 1 | 3 | 0 | €63.00 | €109.59 | 73.944% |
| Evolus Inc | 6 | 1 | 1 | 1 | €11.80 | €20.26 | 71.656% |
| UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €457.55 | €543.72 | 18.833% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 4 | 0 | €39.80 | €84.74 | 112.925% |
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | €61.00 | €83.81 | 37.401% |
| Henry Schein Inc. | 11 | 1 | 0 | 0 | €62.96 | €79.30 | 25.954% |
| Abeona Therapeutics Inc. | 3 | 1 | 1 | 0 | €4.28 | €34.41 | 704.033% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| Stoke Therapeutics Inc | 13 | 1 | 2 | 0 | €11.20 | €21.00 | 87.532% |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.46 | €3.70 | 152.732% |
| Merck & Co. Inc. | 28 | 1 | 3 | 0 | €118.60 | €124.92 | 5.331% |
| Syros Pharmaceuticals Inc. | 5 | 1 | 1 | 1 | €4.78 | €12.80 | 167.814% |
| Medtronic plc | 10 | 1 | 0 | 0 | €75.89 | €94.38 | 24.365% |
| Masimo Corp. | 7 | 1 | 2 | 0 | €127.05 | €147.62 | 16.187% |
| EyePoint Pharmaceuticals Inc. | 14 | 1 | 0 | 1 | €18.33 | €28.17 | 53.670% |
| Owens & Minor Inc. | 2 | 1 | 0 | 0 | €22.20 | €24.04 | 8.298% |
| Johnson & Johnson | 32 | 1 | 2 | 0 | €138.72 | €196.74 | 41.822% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 6 | 1 | €889.20 | €957.22 | 7.650% |
| Zoetis Inc. A | 21 | 1 | 3 | 1 | €155.28 | €200.06 | 28.837% |
| Incyte Corp. | 12 | 2 | 3 | 1 | €49.94 | €78.42 | 57.033% |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 4 | 0 | €372.60 | €382.71 | 2.712% |
| Codexis Inc. | 5 | 2 | 1 | 0 | €3.65 | €8.36 | 129.161% |
| Compugen Ltd. | 2 | 2 | 0 | 0 | €2.01 | €3.67 | 82.813% |
| Myriad Genetics | 5 | 2 | 0 | 0 | €18.10 | €23.22 | 28.273% |